PEAK Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

This study has been completed.

Study NCT00087607 Information provided by Hoffmann-La Roche

First Received: July 12, 2004 Last Updated: May 13, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2006
Estimated Primary Completion Date:	No date given